Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colo-rectal Cancer, +25 more
Locations
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

NCT05608291

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UC San Diego La Jolla, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • The Melanoma And Skin Cancer Institute Englewood, Colorado, United States
View all 211 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

NCT04835805

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • California Pacific Medical Center Research Institute San Francisco, California, United States
  • UCSF Helen Diller Family CCC San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View all 18 locations
View Trial Details

Related conditions